Global Adult Vaccines Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Adult Vaccines market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
The Global Info Research report includes an overview of the development of the Adult Vaccines industry chain, the market status of Private Healthcare Firms (Monovalent Vaccines, Multivalent Vaccines), Government Hospitals (Monovalent Vaccines, Multivalent Vaccines), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Adult Vaccines.
Regionally, the report analyzes the Adult Vaccines markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Adult Vaccines market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Adult Vaccines market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Adult Vaccines industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Monovalent Vaccines, Multivalent Vaccines).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Adult Vaccines market.
Regional Analysis: The report involves examining the Adult Vaccines market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Adult Vaccines market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Adult Vaccines:
Company Analysis: Report covers individual Adult Vaccines manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Adult Vaccines This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Private Healthcare Firms, Government Hospitals).
Technology Analysis: Report covers specific technologies relevant to Adult Vaccines. It assesses the current state, advancements, and potential future developments in Adult Vaccines areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Adult Vaccines market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Adult Vaccines market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Adult Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Adult Vaccines, with price, sales, revenue and global market share of Adult Vaccines from 2018 to 2023.
Chapter 3, the Adult Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Adult Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Adult Vaccines market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Adult Vaccines.
Chapter 14 and 15, to describe Adult Vaccines sales channel, distributors, customers, research findings and conclusion.
The Global Info Research report includes an overview of the development of the Adult Vaccines industry chain, the market status of Private Healthcare Firms (Monovalent Vaccines, Multivalent Vaccines), Government Hospitals (Monovalent Vaccines, Multivalent Vaccines), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Adult Vaccines.
Regionally, the report analyzes the Adult Vaccines markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Adult Vaccines market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Adult Vaccines market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Adult Vaccines industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Monovalent Vaccines, Multivalent Vaccines).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Adult Vaccines market.
Regional Analysis: The report involves examining the Adult Vaccines market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Adult Vaccines market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Adult Vaccines:
Company Analysis: Report covers individual Adult Vaccines manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Adult Vaccines This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Private Healthcare Firms, Government Hospitals).
Technology Analysis: Report covers specific technologies relevant to Adult Vaccines. It assesses the current state, advancements, and potential future developments in Adult Vaccines areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Adult Vaccines market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Adult Vaccines market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Monovalent Vaccines
- Multivalent Vaccines
- Private Healthcare Firms
- Government Hospitals
- Solvay Pharmaceuticals
- Moderna
- BioCSL (Seqirus)
- Aventis Pasteur
- Sanofi Pasteur
- Pfizer Inc.
- Merck & Co. Inc.
- GlaxoSmithKline Plc
- Novartis AG
- Johnson & Johnson
- BioNTech
- Bharat Biotech International Limited
- Zhifei
- Wyeth Vaccines
- AstraZeneca Plc
- Medimmune
- Sinovac
- Baxter International Healthcare Company
- Chiron Vaccines
- Serum Institute of India.
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Adult Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Adult Vaccines, with price, sales, revenue and global market share of Adult Vaccines from 2018 to 2023.
Chapter 3, the Adult Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Adult Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Adult Vaccines market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Adult Vaccines.
Chapter 14 and 15, to describe Adult Vaccines sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Adult Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Adult Vaccines Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Monovalent Vaccines
1.3.3 Multivalent Vaccines
1.4 Market Analysis by Application
1.4.1 Overview: Global Adult Vaccines Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Private Healthcare Firms
1.4.3 Government Hospitals
1.5 Global Adult Vaccines Market Size & Forecast
1.5.1 Global Adult Vaccines Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Adult Vaccines Sales Quantity (2018-2029)
1.5.3 Global Adult Vaccines Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Solvay Pharmaceuticals
2.1.1 Solvay Pharmaceuticals Details
2.1.2 Solvay Pharmaceuticals Major Business
2.1.3 Solvay Pharmaceuticals Adult Vaccines Product and Services
2.1.4 Solvay Pharmaceuticals Adult Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Solvay Pharmaceuticals Recent Developments/Updates
2.2 Moderna
2.2.1 Moderna Details
2.2.2 Moderna Major Business
2.2.3 Moderna Adult Vaccines Product and Services
2.2.4 Moderna Adult Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Moderna Recent Developments/Updates
2.3 BioCSL (Seqirus)
2.3.1 BioCSL (Seqirus) Details
2.3.2 BioCSL (Seqirus) Major Business
2.3.3 BioCSL (Seqirus) Adult Vaccines Product and Services
2.3.4 BioCSL (Seqirus) Adult Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 BioCSL (Seqirus) Recent Developments/Updates
2.4 Aventis Pasteur
2.4.1 Aventis Pasteur Details
2.4.2 Aventis Pasteur Major Business
2.4.3 Aventis Pasteur Adult Vaccines Product and Services
2.4.4 Aventis Pasteur Adult Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Aventis Pasteur Recent Developments/Updates
2.5 Sanofi Pasteur
2.5.1 Sanofi Pasteur Details
2.5.2 Sanofi Pasteur Major Business
2.5.3 Sanofi Pasteur Adult Vaccines Product and Services
2.5.4 Sanofi Pasteur Adult Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Sanofi Pasteur Recent Developments/Updates
2.6 Pfizer Inc.
2.6.1 Pfizer Inc. Details
2.6.2 Pfizer Inc. Major Business
2.6.3 Pfizer Inc. Adult Vaccines Product and Services
2.6.4 Pfizer Inc. Adult Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Pfizer Inc. Recent Developments/Updates
2.7 Merck & Co. Inc.
2.7.1 Merck & Co. Inc. Details
2.7.2 Merck & Co. Inc. Major Business
2.7.3 Merck & Co. Inc. Adult Vaccines Product and Services
2.7.4 Merck & Co. Inc. Adult Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Merck & Co. Inc. Recent Developments/Updates
2.8 GlaxoSmithKline Plc
2.8.1 GlaxoSmithKline Plc Details
2.8.2 GlaxoSmithKline Plc Major Business
2.8.3 GlaxoSmithKline Plc Adult Vaccines Product and Services
2.8.4 GlaxoSmithKline Plc Adult Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 GlaxoSmithKline Plc Recent Developments/Updates
2.9 Novartis AG
2.9.1 Novartis AG Details
2.9.2 Novartis AG Major Business
2.9.3 Novartis AG Adult Vaccines Product and Services
2.9.4 Novartis AG Adult Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Novartis AG Recent Developments/Updates
2.10 Johnson & Johnson
2.10.1 Johnson & Johnson Details
2.10.2 Johnson & Johnson Major Business
2.10.3 Johnson & Johnson Adult Vaccines Product and Services
2.10.4 Johnson & Johnson Adult Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Johnson & Johnson Recent Developments/Updates
2.11 BioNTech
2.11.1 BioNTech Details
2.11.2 BioNTech Major Business
2.11.3 BioNTech Adult Vaccines Product and Services
2.11.4 BioNTech Adult Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 BioNTech Recent Developments/Updates
2.12 Bharat Biotech International Limited
2.12.1 Bharat Biotech International Limited Details
2.12.2 Bharat Biotech International Limited Major Business
2.12.3 Bharat Biotech International Limited Adult Vaccines Product and Services
2.12.4 Bharat Biotech International Limited Adult Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Bharat Biotech International Limited Recent Developments/Updates
2.13 Zhifei
2.13.1 Zhifei Details
2.13.2 Zhifei Major Business
2.13.3 Zhifei Adult Vaccines Product and Services
2.13.4 Zhifei Adult Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Zhifei Recent Developments/Updates
2.14 Wyeth Vaccines
2.14.1 Wyeth Vaccines Details
2.14.2 Wyeth Vaccines Major Business
2.14.3 Wyeth Vaccines Adult Vaccines Product and Services
2.14.4 Wyeth Vaccines Adult Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Wyeth Vaccines Recent Developments/Updates
2.15 AstraZeneca Plc
2.15.1 AstraZeneca Plc Details
2.15.2 AstraZeneca Plc Major Business
2.15.3 AstraZeneca Plc Adult Vaccines Product and Services
2.15.4 AstraZeneca Plc Adult Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 AstraZeneca Plc Recent Developments/Updates
2.16 Medimmune
2.16.1 Medimmune Details
2.16.2 Medimmune Major Business
2.16.3 Medimmune Adult Vaccines Product and Services
2.16.4 Medimmune Adult Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Medimmune Recent Developments/Updates
2.17 Sinovac
2.17.1 Sinovac Details
2.17.2 Sinovac Major Business
2.17.3 Sinovac Adult Vaccines Product and Services
2.17.4 Sinovac Adult Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Sinovac Recent Developments/Updates
2.18 Baxter International Healthcare Company
2.18.1 Baxter International Healthcare Company Details
2.18.2 Baxter International Healthcare Company Major Business
2.18.3 Baxter International Healthcare Company Adult Vaccines Product and Services
2.18.4 Baxter International Healthcare Company Adult Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Baxter International Healthcare Company Recent Developments/Updates
2.19 Chiron Vaccines
2.19.1 Chiron Vaccines Details
2.19.2 Chiron Vaccines Major Business
2.19.3 Chiron Vaccines Adult Vaccines Product and Services
2.19.4 Chiron Vaccines Adult Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Chiron Vaccines Recent Developments/Updates
2.20 Serum Institute of India.
2.20.1 Serum Institute of India. Details
2.20.2 Serum Institute of India. Major Business
2.20.3 Serum Institute of India. Adult Vaccines Product and Services
2.20.4 Serum Institute of India. Adult Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Serum Institute of India. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ADULT VACCINES BY MANUFACTURER
3.1 Global Adult Vaccines Sales Quantity by Manufacturer (2018-2023)
3.2 Global Adult Vaccines Revenue by Manufacturer (2018-2023)
3.3 Global Adult Vaccines Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Adult Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Adult Vaccines Manufacturer Market Share in 2022
3.4.2 Top 6 Adult Vaccines Manufacturer Market Share in 2022
3.5 Adult Vaccines Market: Overall Company Footprint Analysis
3.5.1 Adult Vaccines Market: Region Footprint
3.5.2 Adult Vaccines Market: Company Product Type Footprint
3.5.3 Adult Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Adult Vaccines Market Size by Region
4.1.1 Global Adult Vaccines Sales Quantity by Region (2018-2029)
4.1.2 Global Adult Vaccines Consumption Value by Region (2018-2029)
4.1.3 Global Adult Vaccines Average Price by Region (2018-2029)
4.2 North America Adult Vaccines Consumption Value (2018-2029)
4.3 Europe Adult Vaccines Consumption Value (2018-2029)
4.4 Asia-Pacific Adult Vaccines Consumption Value (2018-2029)
4.5 South America Adult Vaccines Consumption Value (2018-2029)
4.6 Middle East and Africa Adult Vaccines Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Adult Vaccines Sales Quantity by Type (2018-2029)
5.2 Global Adult Vaccines Consumption Value by Type (2018-2029)
5.3 Global Adult Vaccines Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Adult Vaccines Sales Quantity by Application (2018-2029)
6.2 Global Adult Vaccines Consumption Value by Application (2018-2029)
6.3 Global Adult Vaccines Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Adult Vaccines Sales Quantity by Type (2018-2029)
7.2 North America Adult Vaccines Sales Quantity by Application (2018-2029)
7.3 North America Adult Vaccines Market Size by Country
7.3.1 North America Adult Vaccines Sales Quantity by Country (2018-2029)
7.3.2 North America Adult Vaccines Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Adult Vaccines Sales Quantity by Type (2018-2029)
8.2 Europe Adult Vaccines Sales Quantity by Application (2018-2029)
8.3 Europe Adult Vaccines Market Size by Country
8.3.1 Europe Adult Vaccines Sales Quantity by Country (2018-2029)
8.3.2 Europe Adult Vaccines Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Adult Vaccines Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Adult Vaccines Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Adult Vaccines Market Size by Region
9.3.1 Asia-Pacific Adult Vaccines Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Adult Vaccines Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Adult Vaccines Sales Quantity by Type (2018-2029)
10.2 South America Adult Vaccines Sales Quantity by Application (2018-2029)
10.3 South America Adult Vaccines Market Size by Country
10.3.1 South America Adult Vaccines Sales Quantity by Country (2018-2029)
10.3.2 South America Adult Vaccines Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Adult Vaccines Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Adult Vaccines Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Adult Vaccines Market Size by Country
11.3.1 Middle East & Africa Adult Vaccines Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Adult Vaccines Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Adult Vaccines Market Drivers
12.2 Adult Vaccines Market Restraints
12.3 Adult Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Adult Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Adult Vaccines
13.3 Adult Vaccines Production Process
13.4 Adult Vaccines Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Adult Vaccines Typical Distributors
14.3 Adult Vaccines Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Adult Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Adult Vaccines Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Monovalent Vaccines
1.3.3 Multivalent Vaccines
1.4 Market Analysis by Application
1.4.1 Overview: Global Adult Vaccines Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Private Healthcare Firms
1.4.3 Government Hospitals
1.5 Global Adult Vaccines Market Size & Forecast
1.5.1 Global Adult Vaccines Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Adult Vaccines Sales Quantity (2018-2029)
1.5.3 Global Adult Vaccines Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Solvay Pharmaceuticals
2.1.1 Solvay Pharmaceuticals Details
2.1.2 Solvay Pharmaceuticals Major Business
2.1.3 Solvay Pharmaceuticals Adult Vaccines Product and Services
2.1.4 Solvay Pharmaceuticals Adult Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Solvay Pharmaceuticals Recent Developments/Updates
2.2 Moderna
2.2.1 Moderna Details
2.2.2 Moderna Major Business
2.2.3 Moderna Adult Vaccines Product and Services
2.2.4 Moderna Adult Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Moderna Recent Developments/Updates
2.3 BioCSL (Seqirus)
2.3.1 BioCSL (Seqirus) Details
2.3.2 BioCSL (Seqirus) Major Business
2.3.3 BioCSL (Seqirus) Adult Vaccines Product and Services
2.3.4 BioCSL (Seqirus) Adult Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 BioCSL (Seqirus) Recent Developments/Updates
2.4 Aventis Pasteur
2.4.1 Aventis Pasteur Details
2.4.2 Aventis Pasteur Major Business
2.4.3 Aventis Pasteur Adult Vaccines Product and Services
2.4.4 Aventis Pasteur Adult Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Aventis Pasteur Recent Developments/Updates
2.5 Sanofi Pasteur
2.5.1 Sanofi Pasteur Details
2.5.2 Sanofi Pasteur Major Business
2.5.3 Sanofi Pasteur Adult Vaccines Product and Services
2.5.4 Sanofi Pasteur Adult Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Sanofi Pasteur Recent Developments/Updates
2.6 Pfizer Inc.
2.6.1 Pfizer Inc. Details
2.6.2 Pfizer Inc. Major Business
2.6.3 Pfizer Inc. Adult Vaccines Product and Services
2.6.4 Pfizer Inc. Adult Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Pfizer Inc. Recent Developments/Updates
2.7 Merck & Co. Inc.
2.7.1 Merck & Co. Inc. Details
2.7.2 Merck & Co. Inc. Major Business
2.7.3 Merck & Co. Inc. Adult Vaccines Product and Services
2.7.4 Merck & Co. Inc. Adult Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Merck & Co. Inc. Recent Developments/Updates
2.8 GlaxoSmithKline Plc
2.8.1 GlaxoSmithKline Plc Details
2.8.2 GlaxoSmithKline Plc Major Business
2.8.3 GlaxoSmithKline Plc Adult Vaccines Product and Services
2.8.4 GlaxoSmithKline Plc Adult Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 GlaxoSmithKline Plc Recent Developments/Updates
2.9 Novartis AG
2.9.1 Novartis AG Details
2.9.2 Novartis AG Major Business
2.9.3 Novartis AG Adult Vaccines Product and Services
2.9.4 Novartis AG Adult Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Novartis AG Recent Developments/Updates
2.10 Johnson & Johnson
2.10.1 Johnson & Johnson Details
2.10.2 Johnson & Johnson Major Business
2.10.3 Johnson & Johnson Adult Vaccines Product and Services
2.10.4 Johnson & Johnson Adult Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Johnson & Johnson Recent Developments/Updates
2.11 BioNTech
2.11.1 BioNTech Details
2.11.2 BioNTech Major Business
2.11.3 BioNTech Adult Vaccines Product and Services
2.11.4 BioNTech Adult Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 BioNTech Recent Developments/Updates
2.12 Bharat Biotech International Limited
2.12.1 Bharat Biotech International Limited Details
2.12.2 Bharat Biotech International Limited Major Business
2.12.3 Bharat Biotech International Limited Adult Vaccines Product and Services
2.12.4 Bharat Biotech International Limited Adult Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Bharat Biotech International Limited Recent Developments/Updates
2.13 Zhifei
2.13.1 Zhifei Details
2.13.2 Zhifei Major Business
2.13.3 Zhifei Adult Vaccines Product and Services
2.13.4 Zhifei Adult Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Zhifei Recent Developments/Updates
2.14 Wyeth Vaccines
2.14.1 Wyeth Vaccines Details
2.14.2 Wyeth Vaccines Major Business
2.14.3 Wyeth Vaccines Adult Vaccines Product and Services
2.14.4 Wyeth Vaccines Adult Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Wyeth Vaccines Recent Developments/Updates
2.15 AstraZeneca Plc
2.15.1 AstraZeneca Plc Details
2.15.2 AstraZeneca Plc Major Business
2.15.3 AstraZeneca Plc Adult Vaccines Product and Services
2.15.4 AstraZeneca Plc Adult Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 AstraZeneca Plc Recent Developments/Updates
2.16 Medimmune
2.16.1 Medimmune Details
2.16.2 Medimmune Major Business
2.16.3 Medimmune Adult Vaccines Product and Services
2.16.4 Medimmune Adult Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Medimmune Recent Developments/Updates
2.17 Sinovac
2.17.1 Sinovac Details
2.17.2 Sinovac Major Business
2.17.3 Sinovac Adult Vaccines Product and Services
2.17.4 Sinovac Adult Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Sinovac Recent Developments/Updates
2.18 Baxter International Healthcare Company
2.18.1 Baxter International Healthcare Company Details
2.18.2 Baxter International Healthcare Company Major Business
2.18.3 Baxter International Healthcare Company Adult Vaccines Product and Services
2.18.4 Baxter International Healthcare Company Adult Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Baxter International Healthcare Company Recent Developments/Updates
2.19 Chiron Vaccines
2.19.1 Chiron Vaccines Details
2.19.2 Chiron Vaccines Major Business
2.19.3 Chiron Vaccines Adult Vaccines Product and Services
2.19.4 Chiron Vaccines Adult Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Chiron Vaccines Recent Developments/Updates
2.20 Serum Institute of India.
2.20.1 Serum Institute of India. Details
2.20.2 Serum Institute of India. Major Business
2.20.3 Serum Institute of India. Adult Vaccines Product and Services
2.20.4 Serum Institute of India. Adult Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Serum Institute of India. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ADULT VACCINES BY MANUFACTURER
3.1 Global Adult Vaccines Sales Quantity by Manufacturer (2018-2023)
3.2 Global Adult Vaccines Revenue by Manufacturer (2018-2023)
3.3 Global Adult Vaccines Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Adult Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Adult Vaccines Manufacturer Market Share in 2022
3.4.2 Top 6 Adult Vaccines Manufacturer Market Share in 2022
3.5 Adult Vaccines Market: Overall Company Footprint Analysis
3.5.1 Adult Vaccines Market: Region Footprint
3.5.2 Adult Vaccines Market: Company Product Type Footprint
3.5.3 Adult Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Adult Vaccines Market Size by Region
4.1.1 Global Adult Vaccines Sales Quantity by Region (2018-2029)
4.1.2 Global Adult Vaccines Consumption Value by Region (2018-2029)
4.1.3 Global Adult Vaccines Average Price by Region (2018-2029)
4.2 North America Adult Vaccines Consumption Value (2018-2029)
4.3 Europe Adult Vaccines Consumption Value (2018-2029)
4.4 Asia-Pacific Adult Vaccines Consumption Value (2018-2029)
4.5 South America Adult Vaccines Consumption Value (2018-2029)
4.6 Middle East and Africa Adult Vaccines Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Adult Vaccines Sales Quantity by Type (2018-2029)
5.2 Global Adult Vaccines Consumption Value by Type (2018-2029)
5.3 Global Adult Vaccines Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Adult Vaccines Sales Quantity by Application (2018-2029)
6.2 Global Adult Vaccines Consumption Value by Application (2018-2029)
6.3 Global Adult Vaccines Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Adult Vaccines Sales Quantity by Type (2018-2029)
7.2 North America Adult Vaccines Sales Quantity by Application (2018-2029)
7.3 North America Adult Vaccines Market Size by Country
7.3.1 North America Adult Vaccines Sales Quantity by Country (2018-2029)
7.3.2 North America Adult Vaccines Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Adult Vaccines Sales Quantity by Type (2018-2029)
8.2 Europe Adult Vaccines Sales Quantity by Application (2018-2029)
8.3 Europe Adult Vaccines Market Size by Country
8.3.1 Europe Adult Vaccines Sales Quantity by Country (2018-2029)
8.3.2 Europe Adult Vaccines Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Adult Vaccines Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Adult Vaccines Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Adult Vaccines Market Size by Region
9.3.1 Asia-Pacific Adult Vaccines Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Adult Vaccines Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Adult Vaccines Sales Quantity by Type (2018-2029)
10.2 South America Adult Vaccines Sales Quantity by Application (2018-2029)
10.3 South America Adult Vaccines Market Size by Country
10.3.1 South America Adult Vaccines Sales Quantity by Country (2018-2029)
10.3.2 South America Adult Vaccines Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Adult Vaccines Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Adult Vaccines Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Adult Vaccines Market Size by Country
11.3.1 Middle East & Africa Adult Vaccines Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Adult Vaccines Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Adult Vaccines Market Drivers
12.2 Adult Vaccines Market Restraints
12.3 Adult Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Adult Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Adult Vaccines
13.3 Adult Vaccines Production Process
13.4 Adult Vaccines Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Adult Vaccines Typical Distributors
14.3 Adult Vaccines Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Adult Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Adult Vaccines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Solvay Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. Solvay Pharmaceuticals Major Business
Table 5. Solvay Pharmaceuticals Adult Vaccines Product and Services
Table 6. Solvay Pharmaceuticals Adult Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Solvay Pharmaceuticals Recent Developments/Updates
Table 8. Moderna Basic Information, Manufacturing Base and Competitors
Table 9. Moderna Major Business
Table 10. Moderna Adult Vaccines Product and Services
Table 11. Moderna Adult Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Moderna Recent Developments/Updates
Table 13. BioCSL (Seqirus) Basic Information, Manufacturing Base and Competitors
Table 14. BioCSL (Seqirus) Major Business
Table 15. BioCSL (Seqirus) Adult Vaccines Product and Services
Table 16. BioCSL (Seqirus) Adult Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. BioCSL (Seqirus) Recent Developments/Updates
Table 18. Aventis Pasteur Basic Information, Manufacturing Base and Competitors
Table 19. Aventis Pasteur Major Business
Table 20. Aventis Pasteur Adult Vaccines Product and Services
Table 21. Aventis Pasteur Adult Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Aventis Pasteur Recent Developments/Updates
Table 23. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 24. Sanofi Pasteur Major Business
Table 25. Sanofi Pasteur Adult Vaccines Product and Services
Table 26. Sanofi Pasteur Adult Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Sanofi Pasteur Recent Developments/Updates
Table 28. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 29. Pfizer Inc. Major Business
Table 30. Pfizer Inc. Adult Vaccines Product and Services
Table 31. Pfizer Inc. Adult Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Pfizer Inc. Recent Developments/Updates
Table 33. Merck & Co. Inc. Basic Information, Manufacturing Base and Competitors
Table 34. Merck & Co. Inc. Major Business
Table 35. Merck & Co. Inc. Adult Vaccines Product and Services
Table 36. Merck & Co. Inc. Adult Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Merck & Co. Inc. Recent Developments/Updates
Table 38. GlaxoSmithKline Plc Basic Information, Manufacturing Base and Competitors
Table 39. GlaxoSmithKline Plc Major Business
Table 40. GlaxoSmithKline Plc Adult Vaccines Product and Services
Table 41. GlaxoSmithKline Plc Adult Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. GlaxoSmithKline Plc Recent Developments/Updates
Table 43. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 44. Novartis AG Major Business
Table 45. Novartis AG Adult Vaccines Product and Services
Table 46. Novartis AG Adult Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Novartis AG Recent Developments/Updates
Table 48. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 49. Johnson & Johnson Major Business
Table 50. Johnson & Johnson Adult Vaccines Product and Services
Table 51. Johnson & Johnson Adult Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Johnson & Johnson Recent Developments/Updates
Table 53. BioNTech Basic Information, Manufacturing Base and Competitors
Table 54. BioNTech Major Business
Table 55. BioNTech Adult Vaccines Product and Services
Table 56. BioNTech Adult Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. BioNTech Recent Developments/Updates
Table 58. Bharat Biotech International Limited Basic Information, Manufacturing Base and Competitors
Table 59. Bharat Biotech International Limited Major Business
Table 60. Bharat Biotech International Limited Adult Vaccines Product and Services
Table 61. Bharat Biotech International Limited Adult Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Bharat Biotech International Limited Recent Developments/Updates
Table 63. Zhifei Basic Information, Manufacturing Base and Competitors
Table 64. Zhifei Major Business
Table 65. Zhifei Adult Vaccines Product and Services
Table 66. Zhifei Adult Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Zhifei Recent Developments/Updates
Table 68. Wyeth Vaccines Basic Information, Manufacturing Base and Competitors
Table 69. Wyeth Vaccines Major Business
Table 70. Wyeth Vaccines Adult Vaccines Product and Services
Table 71. Wyeth Vaccines Adult Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Wyeth Vaccines Recent Developments/Updates
Table 73. AstraZeneca Plc Basic Information, Manufacturing Base and Competitors
Table 74. AstraZeneca Plc Major Business
Table 75. AstraZeneca Plc Adult Vaccines Product and Services
Table 76. AstraZeneca Plc Adult Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. AstraZeneca Plc Recent Developments/Updates
Table 78. Medimmune Basic Information, Manufacturing Base and Competitors
Table 79. Medimmune Major Business
Table 80. Medimmune Adult Vaccines Product and Services
Table 81. Medimmune Adult Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Medimmune Recent Developments/Updates
Table 83. Sinovac Basic Information, Manufacturing Base and Competitors
Table 84. Sinovac Major Business
Table 85. Sinovac Adult Vaccines Product and Services
Table 86. Sinovac Adult Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Sinovac Recent Developments/Updates
Table 88. Baxter International Healthcare Company Basic Information, Manufacturing Base and Competitors
Table 89. Baxter International Healthcare Company Major Business
Table 90. Baxter International Healthcare Company Adult Vaccines Product and Services
Table 91. Baxter International Healthcare Company Adult Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. Baxter International Healthcare Company Recent Developments/Updates
Table 93. Chiron Vaccines Basic Information, Manufacturing Base and Competitors
Table 94. Chiron Vaccines Major Business
Table 95. Chiron Vaccines Adult Vaccines Product and Services
Table 96. Chiron Vaccines Adult Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 97. Chiron Vaccines Recent Developments/Updates
Table 98. Serum Institute of India. Basic Information, Manufacturing Base and Competitors
Table 99. Serum Institute of India. Major Business
Table 100. Serum Institute of India. Adult Vaccines Product and Services
Table 101. Serum Institute of India. Adult Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 102. Serum Institute of India. Recent Developments/Updates
Table 103. Global Adult Vaccines Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 104. Global Adult Vaccines Revenue by Manufacturer (2018-2023) & (USD Million)
Table 105. Global Adult Vaccines Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 106. Market Position of Manufacturers in Adult Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 107. Head Office and Adult Vaccines Production Site of Key Manufacturer
Table 108. Adult Vaccines Market: Company Product Type Footprint
Table 109. Adult Vaccines Market: Company Product Application Footprint
Table 110. Adult Vaccines New Market Entrants and Barriers to Market Entry
Table 111. Adult Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 112. Global Adult Vaccines Sales Quantity by Region (2018-2023) & (K Units)
Table 113. Global Adult Vaccines Sales Quantity by Region (2024-2029) & (K Units)
Table 114. Global Adult Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 115. Global Adult Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 116. Global Adult Vaccines Average Price by Region (2018-2023) & (US$/Unit)
Table 117. Global Adult Vaccines Average Price by Region (2024-2029) & (US$/Unit)
Table 118. Global Adult Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 119. Global Adult Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 120. Global Adult Vaccines Consumption Value by Type (2018-2023) & (USD Million)
Table 121. Global Adult Vaccines Consumption Value by Type (2024-2029) & (USD Million)
Table 122. Global Adult Vaccines Average Price by Type (2018-2023) & (US$/Unit)
Table 123. Global Adult Vaccines Average Price by Type (2024-2029) & (US$/Unit)
Table 124. Global Adult Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 125. Global Adult Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 126. Global Adult Vaccines Consumption Value by Application (2018-2023) & (USD Million)
Table 127. Global Adult Vaccines Consumption Value by Application (2024-2029) & (USD Million)
Table 128. Global Adult Vaccines Average Price by Application (2018-2023) & (US$/Unit)
Table 129. Global Adult Vaccines Average Price by Application (2024-2029) & (US$/Unit)
Table 130. North America Adult Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 131. North America Adult Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 132. North America Adult Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 133. North America Adult Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 134. North America Adult Vaccines Sales Quantity by Country (2018-2023) & (K Units)
Table 135. North America Adult Vaccines Sales Quantity by Country (2024-2029) & (K Units)
Table 136. North America Adult Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 137. North America Adult Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 138. Europe Adult Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 139. Europe Adult Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 140. Europe Adult Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 141. Europe Adult Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 142. Europe Adult Vaccines Sales Quantity by Country (2018-2023) & (K Units)
Table 143. Europe Adult Vaccines Sales Quantity by Country (2024-2029) & (K Units)
Table 144. Europe Adult Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 145. Europe Adult Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 146. Asia-Pacific Adult Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 147. Asia-Pacific Adult Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 148. Asia-Pacific Adult Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 149. Asia-Pacific Adult Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 150. Asia-Pacific Adult Vaccines Sales Quantity by Region (2018-2023) & (K Units)
Table 151. Asia-Pacific Adult Vaccines Sales Quantity by Region (2024-2029) & (K Units)
Table 152. Asia-Pacific Adult Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 153. Asia-Pacific Adult Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 154. South America Adult Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 155. South America Adult Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 156. South America Adult Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 157. South America Adult Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 158. South America Adult Vaccines Sales Quantity by Country (2018-2023) & (K Units)
Table 159. South America Adult Vaccines Sales Quantity by Country (2024-2029) & (K Units)
Table 160. South America Adult Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 161. South America Adult Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 162. Middle East & Africa Adult Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 163. Middle East & Africa Adult Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 164. Middle East & Africa Adult Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 165. Middle East & Africa Adult Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 166. Middle East & Africa Adult Vaccines Sales Quantity by Region (2018-2023) & (K Units)
Table 167. Middle East & Africa Adult Vaccines Sales Quantity by Region (2024-2029) & (K Units)
Table 168. Middle East & Africa Adult Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 169. Middle East & Africa Adult Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 170. Adult Vaccines Raw Material
Table 171. Key Manufacturers of Adult Vaccines Raw Materials
Table 172. Adult Vaccines Typical Distributors
Table 173. Adult Vaccines Typical Customers
Table 1. Global Adult Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Adult Vaccines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Solvay Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. Solvay Pharmaceuticals Major Business
Table 5. Solvay Pharmaceuticals Adult Vaccines Product and Services
Table 6. Solvay Pharmaceuticals Adult Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Solvay Pharmaceuticals Recent Developments/Updates
Table 8. Moderna Basic Information, Manufacturing Base and Competitors
Table 9. Moderna Major Business
Table 10. Moderna Adult Vaccines Product and Services
Table 11. Moderna Adult Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Moderna Recent Developments/Updates
Table 13. BioCSL (Seqirus) Basic Information, Manufacturing Base and Competitors
Table 14. BioCSL (Seqirus) Major Business
Table 15. BioCSL (Seqirus) Adult Vaccines Product and Services
Table 16. BioCSL (Seqirus) Adult Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. BioCSL (Seqirus) Recent Developments/Updates
Table 18. Aventis Pasteur Basic Information, Manufacturing Base and Competitors
Table 19. Aventis Pasteur Major Business
Table 20. Aventis Pasteur Adult Vaccines Product and Services
Table 21. Aventis Pasteur Adult Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Aventis Pasteur Recent Developments/Updates
Table 23. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 24. Sanofi Pasteur Major Business
Table 25. Sanofi Pasteur Adult Vaccines Product and Services
Table 26. Sanofi Pasteur Adult Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Sanofi Pasteur Recent Developments/Updates
Table 28. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 29. Pfizer Inc. Major Business
Table 30. Pfizer Inc. Adult Vaccines Product and Services
Table 31. Pfizer Inc. Adult Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Pfizer Inc. Recent Developments/Updates
Table 33. Merck & Co. Inc. Basic Information, Manufacturing Base and Competitors
Table 34. Merck & Co. Inc. Major Business
Table 35. Merck & Co. Inc. Adult Vaccines Product and Services
Table 36. Merck & Co. Inc. Adult Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Merck & Co. Inc. Recent Developments/Updates
Table 38. GlaxoSmithKline Plc Basic Information, Manufacturing Base and Competitors
Table 39. GlaxoSmithKline Plc Major Business
Table 40. GlaxoSmithKline Plc Adult Vaccines Product and Services
Table 41. GlaxoSmithKline Plc Adult Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. GlaxoSmithKline Plc Recent Developments/Updates
Table 43. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 44. Novartis AG Major Business
Table 45. Novartis AG Adult Vaccines Product and Services
Table 46. Novartis AG Adult Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Novartis AG Recent Developments/Updates
Table 48. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 49. Johnson & Johnson Major Business
Table 50. Johnson & Johnson Adult Vaccines Product and Services
Table 51. Johnson & Johnson Adult Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Johnson & Johnson Recent Developments/Updates
Table 53. BioNTech Basic Information, Manufacturing Base and Competitors
Table 54. BioNTech Major Business
Table 55. BioNTech Adult Vaccines Product and Services
Table 56. BioNTech Adult Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. BioNTech Recent Developments/Updates
Table 58. Bharat Biotech International Limited Basic Information, Manufacturing Base and Competitors
Table 59. Bharat Biotech International Limited Major Business
Table 60. Bharat Biotech International Limited Adult Vaccines Product and Services
Table 61. Bharat Biotech International Limited Adult Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Bharat Biotech International Limited Recent Developments/Updates
Table 63. Zhifei Basic Information, Manufacturing Base and Competitors
Table 64. Zhifei Major Business
Table 65. Zhifei Adult Vaccines Product and Services
Table 66. Zhifei Adult Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Zhifei Recent Developments/Updates
Table 68. Wyeth Vaccines Basic Information, Manufacturing Base and Competitors
Table 69. Wyeth Vaccines Major Business
Table 70. Wyeth Vaccines Adult Vaccines Product and Services
Table 71. Wyeth Vaccines Adult Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Wyeth Vaccines Recent Developments/Updates
Table 73. AstraZeneca Plc Basic Information, Manufacturing Base and Competitors
Table 74. AstraZeneca Plc Major Business
Table 75. AstraZeneca Plc Adult Vaccines Product and Services
Table 76. AstraZeneca Plc Adult Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. AstraZeneca Plc Recent Developments/Updates
Table 78. Medimmune Basic Information, Manufacturing Base and Competitors
Table 79. Medimmune Major Business
Table 80. Medimmune Adult Vaccines Product and Services
Table 81. Medimmune Adult Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Medimmune Recent Developments/Updates
Table 83. Sinovac Basic Information, Manufacturing Base and Competitors
Table 84. Sinovac Major Business
Table 85. Sinovac Adult Vaccines Product and Services
Table 86. Sinovac Adult Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Sinovac Recent Developments/Updates
Table 88. Baxter International Healthcare Company Basic Information, Manufacturing Base and Competitors
Table 89. Baxter International Healthcare Company Major Business
Table 90. Baxter International Healthcare Company Adult Vaccines Product and Services
Table 91. Baxter International Healthcare Company Adult Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. Baxter International Healthcare Company Recent Developments/Updates
Table 93. Chiron Vaccines Basic Information, Manufacturing Base and Competitors
Table 94. Chiron Vaccines Major Business
Table 95. Chiron Vaccines Adult Vaccines Product and Services
Table 96. Chiron Vaccines Adult Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 97. Chiron Vaccines Recent Developments/Updates
Table 98. Serum Institute of India. Basic Information, Manufacturing Base and Competitors
Table 99. Serum Institute of India. Major Business
Table 100. Serum Institute of India. Adult Vaccines Product and Services
Table 101. Serum Institute of India. Adult Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 102. Serum Institute of India. Recent Developments/Updates
Table 103. Global Adult Vaccines Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 104. Global Adult Vaccines Revenue by Manufacturer (2018-2023) & (USD Million)
Table 105. Global Adult Vaccines Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 106. Market Position of Manufacturers in Adult Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 107. Head Office and Adult Vaccines Production Site of Key Manufacturer
Table 108. Adult Vaccines Market: Company Product Type Footprint
Table 109. Adult Vaccines Market: Company Product Application Footprint
Table 110. Adult Vaccines New Market Entrants and Barriers to Market Entry
Table 111. Adult Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 112. Global Adult Vaccines Sales Quantity by Region (2018-2023) & (K Units)
Table 113. Global Adult Vaccines Sales Quantity by Region (2024-2029) & (K Units)
Table 114. Global Adult Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 115. Global Adult Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 116. Global Adult Vaccines Average Price by Region (2018-2023) & (US$/Unit)
Table 117. Global Adult Vaccines Average Price by Region (2024-2029) & (US$/Unit)
Table 118. Global Adult Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 119. Global Adult Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 120. Global Adult Vaccines Consumption Value by Type (2018-2023) & (USD Million)
Table 121. Global Adult Vaccines Consumption Value by Type (2024-2029) & (USD Million)
Table 122. Global Adult Vaccines Average Price by Type (2018-2023) & (US$/Unit)
Table 123. Global Adult Vaccines Average Price by Type (2024-2029) & (US$/Unit)
Table 124. Global Adult Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 125. Global Adult Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 126. Global Adult Vaccines Consumption Value by Application (2018-2023) & (USD Million)
Table 127. Global Adult Vaccines Consumption Value by Application (2024-2029) & (USD Million)
Table 128. Global Adult Vaccines Average Price by Application (2018-2023) & (US$/Unit)
Table 129. Global Adult Vaccines Average Price by Application (2024-2029) & (US$/Unit)
Table 130. North America Adult Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 131. North America Adult Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 132. North America Adult Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 133. North America Adult Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 134. North America Adult Vaccines Sales Quantity by Country (2018-2023) & (K Units)
Table 135. North America Adult Vaccines Sales Quantity by Country (2024-2029) & (K Units)
Table 136. North America Adult Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 137. North America Adult Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 138. Europe Adult Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 139. Europe Adult Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 140. Europe Adult Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 141. Europe Adult Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 142. Europe Adult Vaccines Sales Quantity by Country (2018-2023) & (K Units)
Table 143. Europe Adult Vaccines Sales Quantity by Country (2024-2029) & (K Units)
Table 144. Europe Adult Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 145. Europe Adult Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 146. Asia-Pacific Adult Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 147. Asia-Pacific Adult Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 148. Asia-Pacific Adult Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 149. Asia-Pacific Adult Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 150. Asia-Pacific Adult Vaccines Sales Quantity by Region (2018-2023) & (K Units)
Table 151. Asia-Pacific Adult Vaccines Sales Quantity by Region (2024-2029) & (K Units)
Table 152. Asia-Pacific Adult Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 153. Asia-Pacific Adult Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 154. South America Adult Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 155. South America Adult Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 156. South America Adult Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 157. South America Adult Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 158. South America Adult Vaccines Sales Quantity by Country (2018-2023) & (K Units)
Table 159. South America Adult Vaccines Sales Quantity by Country (2024-2029) & (K Units)
Table 160. South America Adult Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 161. South America Adult Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 162. Middle East & Africa Adult Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 163. Middle East & Africa Adult Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 164. Middle East & Africa Adult Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 165. Middle East & Africa Adult Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 166. Middle East & Africa Adult Vaccines Sales Quantity by Region (2018-2023) & (K Units)
Table 167. Middle East & Africa Adult Vaccines Sales Quantity by Region (2024-2029) & (K Units)
Table 168. Middle East & Africa Adult Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 169. Middle East & Africa Adult Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 170. Adult Vaccines Raw Material
Table 171. Key Manufacturers of Adult Vaccines Raw Materials
Table 172. Adult Vaccines Typical Distributors
Table 173. Adult Vaccines Typical Customers
LIST OF FIGURES
Figure 1. Adult Vaccines Picture
Figure 2. Global Adult Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Adult Vaccines Consumption Value Market Share by Type in 2022
Figure 4. Monovalent Vaccines Examples
Figure 5. Multivalent Vaccines Examples
Figure 6. Global Adult Vaccines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Adult Vaccines Consumption Value Market Share by Application in 2022
Figure 8. Private Healthcare Firms Examples
Figure 9. Government Hospitals Examples
Figure 10. Global Adult Vaccines Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Adult Vaccines Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Adult Vaccines Sales Quantity (2018-2029) & (K Units)
Figure 13. Global Adult Vaccines Average Price (2018-2029) & (US$/Unit)
Figure 14. Global Adult Vaccines Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Adult Vaccines Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Adult Vaccines by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Adult Vaccines Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Adult Vaccines Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Adult Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Adult Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Adult Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Adult Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Adult Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Adult Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Adult Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Adult Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Adult Vaccines Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Adult Vaccines Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global Adult Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Adult Vaccines Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Adult Vaccines Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America Adult Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Adult Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Adult Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Adult Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Adult Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Adult Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Adult Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Adult Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Adult Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Adult Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Adult Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Adult Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Adult Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Adult Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Adult Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Adult Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Adult Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Adult Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Adult Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Adult Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 52. China Adult Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Adult Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Adult Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Adult Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Adult Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Adult Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Adult Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Adult Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Adult Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Adult Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Adult Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Adult Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Adult Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Adult Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Adult Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Adult Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Adult Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Adult Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Adult Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Adult Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Adult Vaccines Market Drivers
Figure 73. Adult Vaccines Market Restraints
Figure 74. Adult Vaccines Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Adult Vaccines in 2022
Figure 77. Manufacturing Process Analysis of Adult Vaccines
Figure 78. Adult Vaccines Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Figure 1. Adult Vaccines Picture
Figure 2. Global Adult Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Adult Vaccines Consumption Value Market Share by Type in 2022
Figure 4. Monovalent Vaccines Examples
Figure 5. Multivalent Vaccines Examples
Figure 6. Global Adult Vaccines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Adult Vaccines Consumption Value Market Share by Application in 2022
Figure 8. Private Healthcare Firms Examples
Figure 9. Government Hospitals Examples
Figure 10. Global Adult Vaccines Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Adult Vaccines Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Adult Vaccines Sales Quantity (2018-2029) & (K Units)
Figure 13. Global Adult Vaccines Average Price (2018-2029) & (US$/Unit)
Figure 14. Global Adult Vaccines Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Adult Vaccines Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Adult Vaccines by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Adult Vaccines Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Adult Vaccines Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Adult Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Adult Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Adult Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Adult Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Adult Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Adult Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Adult Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Adult Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Adult Vaccines Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Adult Vaccines Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global Adult Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Adult Vaccines Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Adult Vaccines Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America Adult Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Adult Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Adult Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Adult Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Adult Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Adult Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Adult Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Adult Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Adult Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Adult Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Adult Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Adult Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Adult Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Adult Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Adult Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Adult Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Adult Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Adult Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Adult Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Adult Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 52. China Adult Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Adult Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Adult Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Adult Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Adult Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Adult Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Adult Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Adult Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Adult Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Adult Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Adult Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Adult Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Adult Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Adult Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Adult Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Adult Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Adult Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Adult Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Adult Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Adult Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Adult Vaccines Market Drivers
Figure 73. Adult Vaccines Market Restraints
Figure 74. Adult Vaccines Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Adult Vaccines in 2022
Figure 77. Manufacturing Process Analysis of Adult Vaccines
Figure 78. Adult Vaccines Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
